/
PBLA
$0.01+$0.00 (+2,400.00%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $2.50
0% from low
Exchange
OTC Link
CS
Borrow rate
179.78%
Hard to borrow
Price (6 mo)
Loading chart…
Change$-67919.99
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cost of revenue | $5.2M | $6.0M | $3.9M | $4.3M | $5.8M | $10.0M | $35.7M | $25.6M |
| Gross profit | −$5.2M | −$6.0M | −$3.9M | −$4.3M | −$5.8M | −$10.0M | −$35.7M | −$25.6M |
| Gross margin | — | — | — | — | — | — | — | — |
| R&D | $2.5M | $2.6M | $1.8M | $2.3M | $2.5M | $5.4M | $28.0M | $20.6M |
| Operating income | −$5.2M | −$6.0M | −$3.9M | −$4.3M | −$5.8M | −$10.0M | −$34.1M | −$51.3M |
| EBITDA | −$5.2M | −$6.0M | −$1.8M | −$4.4M | −$4.9M | −$10.6M | −$34.7M | −$25.8M |
| Net income | −$5.1M | −$10.4M | −$5.9M | −$6.2M | −$4.8M | −$10.1M | −$34.9M | −$25.3M |
| Net margin | — | — | — | — | — | — | — | — |
| EPS (diluted) | -1974.51 | -3491.75 | -1519.95 | -26103.83 | -14798.10 | -20773.70 | -40748.57 | -232429.55 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $8M | $-3.43 | $-3.43–$-3.43 | 1 |
| 2027 | $35M | $-1.55 | $-1.55–$-1.55 | 1 |
| 2028 | $84M | $0.01 | $0.01–$0.01 | 1 |
Forward consensus · source: Financial Modeling Prep
Peer comparison
PANBELA THERAPEUTICS INC
PANBELA THERAPEUTICS INC
Held by traders on TradeandTell
No one on the platform currently holds PBLA.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in PBLA as of their last filing.
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2024-01-18 | 1-for-20reverse |
| 2023-06-01 | 1-for-30reverse |
| 2023-01-13 | 1-for-40reverse |
Recent trades on TradeandTell
No one on the platform has traded PBLA yet.
